AR078014A1 - Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune - Google Patents
Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmuneInfo
- Publication number
- AR078014A1 AR078014A1 ARP090102151A ARP090102151A AR078014A1 AR 078014 A1 AR078014 A1 AR 078014A1 AR P090102151 A ARP090102151 A AR P090102151A AR P090102151 A ARP090102151 A AR P090102151A AR 078014 A1 AR078014 A1 AR 078014A1
- Authority
- AR
- Argentina
- Prior art keywords
- oligosaccharides
- galactomanar
- bifidobacteria
- mixture
- incubating
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 9
- 210000000987 immune system Anatomy 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- 230000004936 stimulating effect Effects 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 abstract 11
- 241000186000 Bifidobacterium Species 0.000 abstract 4
- 239000000758 substrate Substances 0.000 abstract 4
- 230000004044 response Effects 0.000 abstract 3
- 150000002482 oligosaccharides Chemical class 0.000 abstract 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 102000014171 Milk Proteins Human genes 0.000 abstract 1
- 108010011756 Milk Proteins Proteins 0.000 abstract 1
- 241000031670 Saccharopolyspora thermophila Species 0.000 abstract 1
- 239000005862 Whey Substances 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 108010046377 Whey Proteins Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 1
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 150000003272 mannan oligosaccharides Chemical class 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000021239 milk protein Nutrition 0.000 abstract 1
- 235000021140 nondigestible carbohydrates Nutrition 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000003531 protein hydrolysate Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pediatric Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Composicion nutricional que comprende una combinacion de oligosacáridos no digeribles y un producto obtenido incubando un sustrato acuoso con bifidobacterias y optativamente un producto obtenido incubando un sustrato acuoso con S. thermophilus. Dicha combinacion mejora sinérgicamente el sistema inmune estimulando la respuesta Th1, y o reduciendo la respuesta Th2, mejorando la respuesta a la vacunacion y mejorando la resistencia a las infecciones y/o reduciendo la alergia. Reivindicacion 1: Proceso para la fabricacion de una preparacion caracterizado porque comprende los siguientes pasos: - a: incubar un sustrato acuoso con bifidobacterias, donde el sustrato comprende al menos uno seleccionado del grupo que consiste en leche, proteínas de la leche, suero, proteínas séricas, hidrolizado de proteínas séricas, hidrolizado de caseína y lactosa, para obtener una mezcla incubada; - b: inactivar las bifidobacterias mediante el calentamiento de la mezcla incubada y/o eliminar las células de las bifidobacterias de la mezcla incubada por centrifugacion y/o por filtracion; - c: combinar una composicion que comprende la mezcla obtenida en el paso a o la mezcla obtenida en el paso b, preferiblemente la mezcla obtenida en el paso b con al menos dos hidratos de carbono no digeribles diferentes, donde al menos uno, preferiblemente dos se seleccionan del grupo que consiste en fructo-oligosacáridos, galacto-oligosacáridos, gluco-oligosacáridos, arabinooligosacáridos, manano-oligosacáridos, xilo-oligosacáridos, fuco-oligosacáridos, arabinogalacto-oligosacáridos, glucomano-oligosacáridos, galactomano-oligosacáridos, rafinosa, lactosacarosa, oligosacáridos que comprenden ácido siálico y oligosacáridos que comprenden ácido uronico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2008/050375 WO2009151315A1 (en) | 2008-06-13 | 2008-06-13 | Nutritional composition for infants delivered via caesarean section |
| EP08168054 | 2008-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR078014A1 true AR078014A1 (es) | 2011-10-12 |
Family
ID=40935729
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102151A AR078014A1 (es) | 2008-06-13 | 2009-06-12 | Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune |
| ARP090102156A AR072141A1 (es) | 2008-06-13 | 2009-06-12 | Composicion nutricional para lactantes nacidos por cesarea |
| ARP090102157A AR072142A1 (es) | 2008-06-13 | 2009-06-12 | Nutricion para prevenir infecciones.proceso. composicion. uso. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102156A AR072141A1 (es) | 2008-06-13 | 2009-06-12 | Composicion nutricional para lactantes nacidos por cesarea |
| ARP090102157A AR072142A1 (es) | 2008-06-13 | 2009-06-12 | Nutricion para prevenir infecciones.proceso. composicion. uso. |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US20110182934A1 (es) |
| EP (4) | EP2285387B1 (es) |
| CN (3) | CN102065867A (es) |
| AR (3) | AR078014A1 (es) |
| BR (1) | BRPI0915149B1 (es) |
| DK (1) | DK2285387T3 (es) |
| ES (2) | ES2558960T3 (es) |
| HU (1) | HUE028390T2 (es) |
| PL (2) | PL2293677T3 (es) |
| PT (1) | PT2285387E (es) |
| RU (2) | RU2498605C2 (es) |
| SI (1) | SI2285387T1 (es) |
| WO (3) | WO2009151330A1 (es) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9119414B2 (en) * | 2007-12-07 | 2015-09-01 | N.V. Nutricia | Bifidobacterium for dust mite allergy |
| DK2285387T3 (en) * | 2008-06-13 | 2016-01-25 | Nutricia Nv | Nutrition for preventing infections |
| CA2761444C (en) | 2009-05-11 | 2018-04-24 | Nestec S.A. | Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders |
| EP2552464B1 (en) * | 2010-03-30 | 2018-02-28 | Assistance Publique - Hôpitaux de Paris | Use of bifidobacteria for preventing allergy in breastfed infants |
| WO2011148221A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Lactic acid bacteria for maturation of the enteric nervous system in infants |
| PL3097791T3 (pl) * | 2010-06-04 | 2018-10-31 | N.V. Nutricia | Niestrawne oligosacharydy do doustnej indukcji tolerancji na białka pokarmowe |
| WO2011150949A1 (en) | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| KR101757504B1 (ko) * | 2010-06-28 | 2017-07-12 | 가부시키가이샤 야쿠르트 혼샤 | 경구용 피부 성상 개선제 |
| WO2012057636A1 (en) * | 2010-10-27 | 2012-05-03 | Fonterra Corporate Research And Development Limited | Modulation of th1 and th2 immune response by lactic acid whey |
| EP2449891A1 (en) * | 2010-11-05 | 2012-05-09 | Nestec S.A. | Drinking yoghurt preparations containing non-replicating probiotic micro-organisms |
| CN103582423A (zh) * | 2010-11-11 | 2014-02-12 | 雀巢产品技术援助有限公司 | 含非复制性益生菌微生物的可勺性酸奶制备物 |
| AU2011328073A1 (en) * | 2010-11-11 | 2013-05-02 | Nestec S.A. | Frozen confections containing probiotic micro-organisms |
| EP2465508A1 (en) * | 2010-11-23 | 2012-06-20 | Nestec S.A. | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
| EP2520181A1 (en) * | 2011-05-02 | 2012-11-07 | N.V. Nutricia | Fermented infant formula |
| WO2012078030A1 (en) * | 2010-12-06 | 2012-06-14 | N.V. Nutricia | Fermented infant formula |
| HUE026180T2 (en) * | 2010-12-06 | 2016-05-30 | Nutricia Nv | Fermented Child Nutrition |
| WO2012078032A1 (en) | 2010-12-10 | 2012-06-14 | N.V. Nutricia | Early stimulation of taste and/or flavour acceptance |
| SG10201707519PA (en) * | 2010-12-31 | 2017-10-30 | Abbott Lab | Neutral human milk oligosaccharides to promote growth of beneficial bacteria |
| EP2481299B1 (en) * | 2011-01-31 | 2016-12-07 | Dr. Fischer Gesundheitsprodukte GmbH | Bifidobacterium bifidum strains for application in gastrointestinal diseases |
| ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
| WO2013053073A1 (zh) * | 2011-10-10 | 2013-04-18 | Huang Daiyong | 一种基于甘露寡糖的胃肠道健康因子组合物 |
| WO2013187755A1 (en) * | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
| WO2014070016A2 (en) * | 2012-11-02 | 2014-05-08 | N.V. Nutricia | Synbiotics combination for brain improvement |
| CA2902452C (en) * | 2013-02-28 | 2018-09-04 | Full Spectrum Laboratories Limited | Chemical engineering processes and apparatus for the synthesis of compounds |
| US20140271978A1 (en) * | 2013-03-15 | 2014-09-18 | Mead Johnson Nutrition Company | Low-buffer nutritional compositions and uses thereof |
| US9352020B2 (en) * | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| CN105263343B (zh) * | 2013-04-08 | 2019-03-08 | N·V·努特里奇亚 | 含有巯基蛋白酶抑制剂的发酵营养组合物 |
| WO2014200334A1 (en) * | 2013-06-14 | 2014-12-18 | N.V. Nutricia | Synbiotic composition for treatment of infections in allergic patients |
| CN104413334A (zh) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | 可食用组合物及其制备方法和用途 |
| EP2857410A1 (en) | 2013-10-04 | 2015-04-08 | Jennewein Biotechnologie GmbH | Process for purification of 2´-fucosyllactose using simulated moving bed chromatography |
| PT3111942T (pt) | 2013-11-15 | 2021-03-23 | Nestle Sa | Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco |
| EP3082473A2 (en) * | 2013-12-19 | 2016-10-26 | Nestec S.A. | Nutritional composition to reduce metabolic stress in infants |
| AU2015308136B2 (en) | 2014-08-25 | 2020-07-09 | Teewinot Technologies Limited | Apparatus and methods for the simultaneous production of cannabinoid compounds |
| EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
| WO2017043962A1 (en) * | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Method for stimulating microbiota health after non-natural birth |
| EP3150257A1 (en) * | 2015-09-30 | 2017-04-05 | Buga, Doris | A method for producing a composition for strengthening the immune system |
| CN105341938B (zh) * | 2015-10-10 | 2018-06-26 | 北京康比特体育科技股份有限公司 | 一种降低大强度运动后呼吸道感染率的保健食品 |
| WO2017117142A1 (en) | 2015-12-28 | 2017-07-06 | New York University | Device and method of restoring microbiota of newborns |
| WO2017114901A1 (en) * | 2015-12-29 | 2017-07-06 | N.V. Nutricia | Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria |
| BR112018013501B1 (pt) * | 2015-12-29 | 2022-12-20 | N.V. Nutricia | Uso de um ingrediente fermentado e oligossacarídeo não digerível |
| EP3841892A1 (en) | 2016-05-10 | 2021-06-30 | N.V. Nutricia | Fermented infant formula |
| CN109475165A (zh) | 2016-05-10 | 2019-03-15 | N·V·努特里奇亚 | 发酵的婴儿配方物 |
| AU2016424981C1 (en) * | 2016-09-30 | 2024-10-10 | The A2 Milk Company Limited | Beta-caseins and gut microbiota |
| EP3592363A1 (en) * | 2017-03-08 | 2020-01-15 | N.V. Nutricia | Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation |
| WO2019008104A1 (en) * | 2017-07-07 | 2019-01-10 | Nestec S.A. | FORTIFYING HUMAN MILK |
| CN107397230A (zh) * | 2017-08-21 | 2017-11-28 | 杭州特悘衡康生物科技有限公司 | 营养组合物、促进手术后肌肉恢复和蛋白质合成的配方食品及其应用 |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| WO2019115382A1 (en) * | 2017-12-11 | 2019-06-20 | N.V. Nutricia | Composition for use for treating delayed colonization by bifidobacterium after birth |
| CN111698993A (zh) | 2018-02-09 | 2020-09-22 | N·V·努特里奇亚 | 含有不可消化寡糖的发酵配方物 |
| WO2019155044A1 (en) | 2018-02-09 | 2019-08-15 | N.V. Nutricia | Fermented formula with non-digestible oligosaccharides |
| EP3646739A1 (en) | 2018-11-01 | 2020-05-06 | N.V. Nutricia | Nutritional composition comprising urea and non-digestible oligosaccharides |
| CN112912088A (zh) | 2019-01-16 | 2021-06-04 | N·V·努特里奇亚 | 用于轮状病毒引起的感染的具有非消化性寡糖的经发酵配方食品 |
| US20210352925A1 (en) * | 2019-02-04 | 2021-11-18 | N.V. Nutricia | Fermented formula with non digestible oligosaccharides for sleep improvement |
| EP3968787A1 (en) | 2019-05-15 | 2022-03-23 | N.V. Nutricia | Fermented formula for improving intestinal development |
| EP3975756A1 (en) * | 2019-05-29 | 2022-04-06 | N.V. Nutricia | Non-digestible oligosaccharides for decreased colonic protein fermentation |
| US20220110985A1 (en) | 2019-06-04 | 2022-04-14 | N.V. Nutricia | Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose |
| PT3883393T (pt) | 2019-06-04 | 2022-12-07 | Nutricia Nv | Composição nutricional compreendendo 2'fucosilactose e butirato dietético |
| CN110839698A (zh) * | 2019-11-29 | 2020-02-28 | 内蒙古伊利实业集团股份有限公司 | 一种组合物及其食品用途 |
| GB2608587A (en) * | 2021-06-25 | 2023-01-11 | Mjn Us Holdings Llc | Use of extensively hydrolysed protein |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4110476A (en) | 1977-01-10 | 1978-08-29 | Johnson/Rhodes Cultured Foods, Inc. | Preparation of liquid and frozen yogurt products |
| RU2031586C1 (ru) * | 1993-02-05 | 1995-03-27 | Тамара Георгиевна Извекова | Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения |
| FR2723963B1 (fr) * | 1994-08-31 | 1997-01-17 | Gervais Danone Co | Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase |
| EP1020123A1 (en) | 1999-01-18 | 2000-07-19 | Sitia-Yomo S.p.A. | Beverages containing live lactic bacteria |
| FR2795917B1 (fr) * | 1999-07-06 | 2001-08-31 | Gervais Danone Sa | Procede de preparation d'un produit lacte immunostimulant et ses applications |
| EP1062873A1 (en) * | 1999-12-13 | 2000-12-27 | N.V. Nutricia | Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate |
| WO2001064225A1 (en) | 2000-03-01 | 2001-09-07 | Societe Des Produits Nestle S.A. | Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| EP1145643A1 (en) | 2000-04-10 | 2001-10-17 | Phillip Connolly | Improved milk protein concentrate |
| US7431939B1 (en) | 2000-09-28 | 2008-10-07 | Mississippi State University | Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| EP1364586A1 (en) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
| RU2220579C1 (ru) * | 2002-07-31 | 2004-01-10 | Зенович Сергей Михайлович | Пищевой преимущественно кисломолочный продукт и закваска для его получения (варианты) |
| OA13142A (en) * | 2002-10-11 | 2006-12-13 | Wyeth Corp | Nutritional formulations containing synbiotic substances. |
| GB0229015D0 (en) * | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| WO2004069156A2 (en) * | 2003-01-30 | 2004-08-19 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
| FR2857026B1 (fr) | 2003-04-16 | 2012-11-16 | Gervais Danone Sa | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant |
| FR2853908B1 (fr) * | 2003-04-16 | 2005-06-03 | Gervais Danone Sa | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant |
| PL1638416T3 (pl) | 2003-06-23 | 2013-09-30 | Nestec Sa | Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej |
| ES2314461T3 (es) * | 2003-10-24 | 2009-03-16 | N.V. Nutricia | Composicion simbiotica para bebes. |
| ES2309901T3 (es) | 2003-10-24 | 2008-12-16 | N.V. Nutricia | Oligosacaridos inmunomoduladores. |
| EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
| US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| PT1841330E (pt) | 2004-12-27 | 2011-03-14 | Nestec Sa | Utilização de fórmula para lactentes com teor proteico reduzido |
| ES2781328T3 (es) * | 2005-02-21 | 2020-09-01 | Nestle Sa | Mezcla de oligosacáridos |
| ES2524344T3 (es) * | 2005-02-28 | 2014-12-05 | N.V. Nutricia | Composición nutritiva con probióticos |
| US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
| US20090156550A1 (en) | 2005-12-06 | 2009-06-18 | Potappel-Van T Land Belinda | Composition containing oligosaccharides for the treatment/prevention of infections |
| WO2007081981A2 (en) | 2006-01-11 | 2007-07-19 | Attune Foods | Probiotic food, process for its preparation and dietary regimen |
| WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
| DK2285387T3 (en) * | 2008-06-13 | 2016-01-25 | Nutricia Nv | Nutrition for preventing infections |
| WO2010008272A1 (en) | 2008-07-15 | 2010-01-21 | N.V. Nutricia | Treatment of gut motility disorders |
| WO2010070613A2 (en) | 2008-12-18 | 2010-06-24 | University College London | Baby feeding formula and system |
| EP2520181A1 (en) | 2011-05-02 | 2012-11-07 | N.V. Nutricia | Fermented infant formula |
| HUE026180T2 (en) | 2010-12-06 | 2016-05-30 | Nutricia Nv | Fermented Child Nutrition |
| WO2012078030A1 (en) | 2010-12-06 | 2012-06-14 | N.V. Nutricia | Fermented infant formula |
| MX2011007872A (es) | 2011-07-26 | 2013-01-29 | Nucitec Sa De Cv | Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento. |
-
2009
- 2009-06-12 DK DK09762710.3T patent/DK2285387T3/en active
- 2009-06-12 US US12/997,527 patent/US20110182934A1/en not_active Abandoned
- 2009-06-12 PT PT97627103T patent/PT2285387E/pt unknown
- 2009-06-12 EP EP09762710.3A patent/EP2285387B1/en active Active
- 2009-06-12 AR ARP090102151A patent/AR078014A1/es unknown
- 2009-06-12 PL PL09762711T patent/PL2293677T3/pl unknown
- 2009-06-12 RU RU2011100829/10A patent/RU2498605C2/ru active
- 2009-06-12 CN CN2009801222425A patent/CN102065867A/zh active Pending
- 2009-06-12 EP EP17205129.4A patent/EP3326633A1/en not_active Withdrawn
- 2009-06-12 WO PCT/NL2009/050332 patent/WO2009151330A1/en active Application Filing
- 2009-06-12 PL PL09762710T patent/PL2285387T3/pl unknown
- 2009-06-12 RU RU2011100828/15A patent/RU2543634C2/ru active
- 2009-06-12 AR ARP090102156A patent/AR072141A1/es unknown
- 2009-06-12 US US12/997,537 patent/US20110117077A1/en not_active Abandoned
- 2009-06-12 ES ES09762710.3T patent/ES2558960T3/es active Active
- 2009-06-12 BR BRPI0915149-4A patent/BRPI0915149B1/pt active IP Right Grant
- 2009-06-12 ES ES09762711.1T patent/ES2656776T3/es active Active
- 2009-06-12 CN CN200980131512.9A patent/CN102123715B/zh active Active
- 2009-06-12 HU HUE09762710A patent/HUE028390T2/en unknown
- 2009-06-12 WO PCT/NL2009/050333 patent/WO2009151331A1/en active Application Filing
- 2009-06-12 WO PCT/NL2009/050330 patent/WO2009151329A1/en active Application Filing
- 2009-06-12 SI SI200931354T patent/SI2285387T1/sl unknown
- 2009-06-12 US US12/997,541 patent/US20110097437A1/en not_active Abandoned
- 2009-06-12 EP EP09762712A patent/EP2293803A1/en not_active Ceased
- 2009-06-12 CN CN200980131387.1A patent/CN102118976B/zh active Active
- 2009-06-12 AR ARP090102157A patent/AR072142A1/es unknown
- 2009-06-12 EP EP09762711.1A patent/EP2293677B1/en active Active
-
2016
- 2016-09-28 US US15/278,475 patent/US20170173104A1/en not_active Abandoned
-
2017
- 2017-01-13 US US15/406,361 patent/US10124016B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR078014A1 (es) | Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune | |
| ES2536247T3 (es) | Producto con base de leche y un método para su preparación | |
| AU2021204020B2 (en) | Nutritional composition and infant formula for promoting myelination of the brain | |
| Arbizu et al. | Commercial whey products promote intestinal barrier function with glycomacropeptide enhanced activity in downregulating bacterial endotoxin lipopolysaccharides (LPS)-induced inflammation in vitro | |
| Oda et al. | Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin | |
| JP6359501B2 (ja) | 酸処理水性乳清タンパク質抽出物を使用したアレルギー治療 | |
| US9730969B2 (en) | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain | |
| US20140170266A1 (en) | Composition with improved digestibility of proteins | |
| RU2013134133A (ru) | Применение содержащих лактоферрин питательных композиций при поддержании устойчивости к заболеваниям и состояниям | |
| JP2014514929A (ja) | 乳タンパク質組成物を製造する方法 | |
| RU2011115185A (ru) | Молочная сыворотка и функция вилочковой железы(тимуса) | |
| CN111587072A (zh) | 组合物和其用途 | |
| JP6258323B2 (ja) | 血清タンパク質濃縮物の調製方法 | |
| WO2024200704A1 (en) | Composition comprising milk extracellular vesicles and galactose | |
| Kramer et al. | MFGM-enriched whey displays antiviral activity against common pediatric viruses in vitro | |
| JP2023135295A (ja) | ＩｇＡ産生促進用組成物 | |
| WO2012087165A1 (en) | Enriched dairy compositions | |
| TH107951B (th) | โภชนาหารเพื่อการกระตุ้นระบบภูมิคุ้มกัน | |
| TH107951A (th) | โภชนาหารเพื่อการกระตุ้นระบบภูมิคุ้มกัน | |
| TH76919B (th) | องค์ประกอบทางโภชนาการสำหรับทารกที่คลอดโดยผ่านทางการผ่าท้องทำคลอด | |
| CZ22848U1 (cs) | Nápoj s obsahem syrovátkových bílkovin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |